If you happen to see a question you know the answer to, please do chime in and help your fellow community members. We encourage our fourm members to be more involved, jump in and help out your fellow researchers with their questions. GATK forum is a community forum and helping each other with using GATK tools and research is the cornerstone of our success as a genomics research community.We appreciate your help!
Test-drive the GATK tools and Best Practices pipelines on Terra
Check out this blog post to learn how you can get started with GATK and try out the pipelines in preconfigured workspaces (with a user-friendly interface!) without having to install anything.
Is joint genotyping suitable for clinical purposes?
I've seen a lot of recommendations and benefits why should I use joint genotyping but still I didn't find a clear answer if it's indeed suitable for clinical applications.
I have to analyse ~20 WES samples per week - these are patients data with various diseases. So for sure I'll have a patient that has an unique variant (singleton) across all my data. Having this knowledge, is it safe to use joint genotyping? According to the description in "Why should I use joint calling for germline short variants?" my singletons may be lost...
So in my case, should I use it or not?
Thank you for any clarifications!